How to Spot Symptoms of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Metabolic Dysfunction-Associated Steatohepatitis (MASH) Symptoms

Metabolic Dysfunction-Associated Steatohepatitis (MASH) Symptoms
iStock
Metabolic dysfunction-associated steatohepatitis (MASH), formally known as nonalcoholic steatohepatitis (NASH), is a liver disease that develops when accumulated liver fat causes inflammation and cellular damage. It’s a severe stage of what was once called nonalcoholic fatty liver disease (NAFLD), now known as metabolic dysfunction-associated steatotic liver disease (MASLD).

When it first develops, MASH often has no symptoms or may only cause general fatigue or discomfort in the abdomen. If the condition progresses, however, its symptoms — such as itching, swelling, excessive bruising, and muscle wasting — will accumulate and become more serious.

Often linked to conditions associated with high blood lipid (fat) levels such as type 2 diabetes and obesity, MASH can lead to lasting liver damage and dangerous conditions such as cirrhosis, liver cancer, and heart issues.

Symptoms of MASH

Early on, MASH often is asymptomatic. Many people don’t realize anything is wrong until their liver shows signs of damage from MASH, which can take years to occur.

When they do occur, early MASH symptoms may include:

  • Persistent fatigue, or feeling tired consistently
  • Discomfort or pain in the upper right abdomen where your liver sits
  • Unexplained weight loss
  • Weakness or general malaise
As cirrhosis damages the liver later in the disease, MASH can have other symptoms, including:

  • Pruritus, or intense itching
  • Ascites, or swelling in the abdomen from fluid buildup
  • Edema, a swelling in the legs
  • Jaundice, a yellowing of the skin and eyes
  • Bruising and bleeding easily
  • Spider angiomas, or blood vessels just under the surface of your skin that look like a spiderweb
  • Hepatic encephalopathy, or a buildup of blood toxins that can cause behavior changes, slurred speech, and confusion

  • Red palms

  • Shortness of breath
  • Internal bleeding

  • Muscle wasting

  • Portal hypertension, or increased pressure in the portal vein that causes the liver and spleen to enlarge

How MASH affects the body
Everyday Health

Stages of MASH

MASH doesn’t appear overnight. It evolves over time as part of MASLD, which is defined by a buildup of unhealthy fat within your liver. The stage of MASH you have depends on how much liver scarring, or fibrosis, you have.

Stage 0 fibrosis is when you have too much fat in your liver but have not yet experienced any liver damage or fibrosis. At this stage, you may be diagnosed with MASLD that hasn’t developed into MASH.

The stages of MASH describe increasing levels of liver damage:

  • Stage 1: MASH with mild fibrosis indicates an early level of liver scarring that can often be reversed with self-care.
  • Stage 2: In MASH with moderate fibrosis, inflammation and cellular damage have caused some liver scarring that could be reversed. Your liver is still working well.
  • Stage 3: MASH with advanced fibrosis includes extensive liver scarring. Some of this damage can be reversed. But at this stage, treatment from healthcare professionals is necessary to prevent further, permanent damage and maintain your liver function.
  • Stage 4: When cirrhosis sets in at this stage, scarring is severe enough to change your liver’s shape. Some of the scarring is permanent, but some damage may still be reversible. Your liver may still function at a reduced capacity, but liver cancer and failure are serious risks.
Stages 0 and 1 may have no symptoms or general ones, such as weakness or fatigue. As liver damage gets closer to cirrhosis in later stages, more serious symptoms such as jaundice and shortness of breath may occur.

Potential Complications of MASH

MASH is the third most common cause of hepatocellular carcinoma, which accounts for 90 percent of liver cancer cases.

 It also can lead to liver failure, in which your liver no longer removes toxins, produces bile, and converts nutrients to energy.

Both are serious issues: The five-year survival rate for people with hepatocellular carcinoma is 21 percent, and end-stage liver failure often requires a transplant.

Liver inflammation from MASH also can affect the heart, kidneys, and muscles.

Cardiovascular disease is the most common cause of death in people with MASH. In addition to a heart attack or stroke, MASH can contribute to heart issues that include:

  • Coronary artery disease
  • Atherosclerosis, a buildup of plaque in the arteries
  • Changes in heart size and shape
  • Heart failure
  • Arrhythmia, or irregular heartbeat
Muscle-related complications of MASH include:

  • Muscular atrophy, in which your muscles progressively weaken and degenerate
  • Sarcopenia, a loss of muscle mass and function
  • Inflammatory myopathies, rare muscle disorders that include skeletal muscle inflammation
Type 2 diabetes also is a complication of MASH, in addition to being a risk factor for it.

When to See a Doctor

Because MASH symptoms can be vague or nonexistent in early stages, it can be difficult to know if you have MASH before it becomes a serious issue.

To help catch the disease before you develop irreversible liver damage, contact your healthcare provider if you experience these symptoms:

  • Jaundice
  • Easy bruising
  • Dark urine
  • Swelling in the abdomen or legs
  • Vomiting blood
  • Dark or black tarry feces
  • Periods of confusion, mood changes, forgetfulness, or poor judgment
  • Unexplained skin itching

The Takeaway

  • MASH is a progressive and potentially serious liver condition, but it may not present symptoms until damage is advanced.
  • Early MASH may include fatigue, pain in the upper right abdomen, weakness, and unexplained weight loss.
  • The earlier MASH is detected, the more likely you can halt or even reverse the damage to your liver.
  • Left untreated, MASH can lead to serious complications such as liver failure and liver cancer, cardiovascular disease and other heart issues, and muscular issues.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Metabolic Dysfunction-Associated Steatohepatitis (MASH). Cleveland Clinic. May 5, 2025.
  2. Corliss J. An often-silent liver condition that threatens the heart. Harvard Health Publishing. January 1, 2025.
  3. Nonalcoholic Fatty Liver Disease. Johns Hopkins Medicine.
  4. Metabolic Dysfunction-Associated Steatohepatitis (MASH) Symptoms. Stanford Medicine.
  5. MASLD and MASH* Symptoms. American Liver Foundation. June 12, 2025.
  6. Hepatic Encephalopathy. American Liver Foundation. July 20, 2022.
  7. Nonalcoholic Fatty Liver Disease. Mayo Clinic. April 4, 2024.
  8. Portal Hypertension. UCLA Health.
  9. MASLD, NAFLD and fatty liver disease. British Liver Trust.
  10. Zheng J et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Nature. February 7, 2025.
  11. MASH Complications. American Liver Foundation. April 2025.
  12. End-Stage Liver Disease. American Liver Foundation. June 12, 2025.
  13. Heptocellular Carcinoma (HCC). Cleveland Clinic. February 13, 2025.
  14. Liver Failure. Cleveland Clinic. June 14, 2024.
  15. Sandireddy R et al. Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases. Frontiers in Cell and Developmental Biology. July 16, 2024.
  16. Sanyal AJ et al. Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review. American Heart Journal Plus. March 24, 2024.
Michelle-Seguin-bio

Michelle Seguin, MD

Medical Reviewer

Michelle Seguin, MD, is a board-certified family medicine, lifestyle medicine, and certified functional medicine physician (IFMCP). She is a practicing physician at Root Functional Medicine, a leading telemedicine practice specializing in personalized, root-cause care.

Joseph Bennington-Castro

Author

Joseph Bennington-Castro is a science writer based in Hawaii. He has written well over a thousand articles for the general public on a wide range topics, including health, astronomy, archaeology, renewable energy, biomaterials, conservation, history, animal behavior, artificial intelligence, and many others.

In addition to writing for Everyday Health, Bennington-Castro has also written for publications such as Scientific American, National Geographic online, USA Today, Materials Research Society, Wired UK, Men's Journal, Live Science, Space.com, NBC News Mach, NOAA Fisheries, io9.com, and Discover.